Zura Bio Limited · NASDAQ:ZURA
Montanova Capital, LLC reported a 9.90% stake in Zura Bio Limited (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 12, 2026
Montanova Capital, LLC reported a 9.90% stake in Zura Bio Limited, 9,524,263 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 9,524,263
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Suvretta Capital Management, LLC | 9.90% | 9,524,263 |
| Averill Master Fund, Ltd. | 8.80% | 8,372,230 |
| Aaron Cowen | 9.90% | 9,524,263 |
Source
Related
- Zura Bio Limited
- Montanova Capital, LLC
- Zura Bio Limited shareholders
- Schedule 13G/A · Montanova Capital, LLC · Feb 13, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · May 15, 2026
- Schedule 13G/A · Great Point Partners LLC · May 15, 2026
- Schedule 13G/A · JPMorgan Chase & Co · May 6, 2026
- Schedule 13D/A · AI Biotechnology LLC · Mar 2, 2026
- Schedule 13G/A · Great Point Partners LLC · Feb 17, 2026